Es gab 50 kürzliche Insider-Transaktionen für Pieris Pharmaceuticals, Inc. (PIRS), darunter 42 Käufe und 5 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $12.03M und die gesamten Insider-Verkäufe auf $2.66M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Geraghty James A, Kiritsy Christopher P, Dellora Investments Lp. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PIRS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-12-12 |
Geraghty James A |
Director |
Aktienrückgabe |
1 |
$0.01 |
$0.01 |
- |
| 2024-12-02 |
Kiritsy Christopher P |
Director |
RSU-Zuteilung |
500 |
$16.43 |
$8.22K |
500 |
| 2024-11-06 |
Dellora Investments Lp |
10 Percent Owner |
Unbekannt |
- |
- |
- |
141,079 |
| 2024-08-12 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Informierter Kauf |
757 |
$15.88 |
$12.02K |
15,067 |
| 2024-08-09 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Informierter Kauf |
3,000 |
$14.89 |
$44.68K |
127,331 |
| 2024-08-07 |
Geraghty James A |
Director |
Informierter Kauf |
1 |
$1.00 |
$1.00 |
1 |
| 2024-07-24 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
14,310 |
| 2023-06-21 |
Geraghty James A |
Director |
RSU-Zuteilung |
45,000 |
$0.26 |
$11.7K |
45,000 |
| 2023-06-21 |
Kiritsy Christopher P |
Director |
RSU-Zuteilung |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Sherman Matthew L |
Director |
RSU-Zuteilung |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Kiener Peter A |
Director |
RSU-Zuteilung |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Richman Michael |
Director |
RSU-Zuteilung |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Barbier Ann |
Director |
RSU-Zuteilung |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Said Maya R. |
Director |
RSU-Zuteilung |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-05-25 |
Kiritsy Christopher P |
Director |
Informierter Kauf |
10,000 |
$0.85 |
$8.5K |
20,000 |
| 2023-05-11 |
Bvf Partners L P/il |
10 Percent Owner |
Veräußerung |
265,000 |
$7.10 |
$1.88M |
- |
| 2023-02-24 |
Yoder Stephen S. |
Chief Executive Officer |
RSU-Zuteilung |
634,021 |
$1.39 |
$881.29K |
634,021 |
| 2023-02-24 |
Bures Thomas |
Chief Financial Officer |
RSU-Zuteilung |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Kaufmann Hitto |
Chief Scientific Officer |
RSU-Zuteilung |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Olwill Shane |
Chief Development Officer |
RSU-Zuteilung |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Mousa Ahmed |
Chief Business Officer |
RSU-Zuteilung |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2022-06-22 |
Geraghty James A |
Director |
RSU-Zuteilung |
45,000 |
- |
- |
45,000 |
| 2022-06-22 |
Kiritsy Christopher P |
Director |
RSU-Zuteilung |
40,000 |
$1.82 |
$72.8K |
40,000 |
| 2022-06-22 |
Sherman Matthew L |
Director |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Kiener Peter A |
Director |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Richman Michael |
Director |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Barbier Ann |
Director |
RSU-Zuteilung |
40,000 |
$1.82 |
$72.8K |
40,000 |
| 2022-06-22 |
Said Maya R. |
Director |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-05-13 |
Demuth Tim |
Chief Medical Officer |
Informierter Kauf |
6,000 |
$1.71 |
$10.26K |
6,000 |
| 2022-02-22 |
Yoder Stephen S. |
Chief Executive Officer |
RSU-Zuteilung |
625,874 |
$3.03 |
$1.9M |
625,874 |
| 2022-02-22 |
Bures Thomas |
Chief Financial Officer |
RSU-Zuteilung |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Kaufmann Hitto |
SVP, Chief Scientific Officer |
RSU-Zuteilung |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Demuth Tim |
Chief Medical Officer |
RSU-Zuteilung |
100,000 |
$3.03 |
$303K |
100,000 |
| 2022-02-22 |
Olwill Shane |
Chief Development Officer |
RSU-Zuteilung |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Mousa Ahmed |
Chief Business Officer |
RSU-Zuteilung |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2021-10-06 |
Mousa Ahmed |
Chief Business Officer |
Veräußerung |
150,000 |
$2.50 |
$375K |
- |
| 2021-08-30 |
Olwill Shane |
Chief Development Officer |
Informierter Verkauf |
29,200 |
$5.15 |
$150.38K |
4,638 |
| 2021-08-01 |
Demuth Tim |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-08-01 |
Demuth Tim |
Chief Medical Officer |
RSU-Zuteilung |
360,000 |
$3.48 |
$1.25M |
360,000 |
| 2021-08-01 |
Olwill Shane |
Chief Development Officer |
Veräußerung |
82,000 |
$3.09 |
$253.38K |
- |
| 2021-06-25 |
Geraghty James A |
Director |
RSU-Zuteilung |
45,000 |
$4.00 |
$180K |
45,000 |
| 2021-06-25 |
Kiritsy Christopher P |
Director |
RSU-Zuteilung |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Sherman Matthew L |
Director |
RSU-Zuteilung |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Kiener Peter A |
Director |
RSU-Zuteilung |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Richman Michael |
Director |
RSU-Zuteilung |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Barbier Ann |
Director |
RSU-Zuteilung |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Said Maya R. |
Director |
RSU-Zuteilung |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-03-04 |
Yoder Stephen S. |
Chief Executive Officer |
RSU-Zuteilung |
530,000 |
$2.50 |
$1.33M |
530,000 |
| 2021-03-04 |
Bures Thomas |
Vice President, Finance |
RSU-Zuteilung |
150,000 |
$2.50 |
$375K |
150,000 |
| 2021-03-04 |
Kaufmann Hitto |
SVP, Chief Scientific Officer |
RSU-Zuteilung |
220,000 |
$2.50 |
$550K |
220,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
